Paper
27 February 1997 BNCT: a promising area of research?
Reinhard Gahbauer, N. Gupta, T. Blue, J. Goodman, J. Grecula, A. H. Soloway, A. Wambersie
Author Affiliations +
Proceedings Volume 2867, International Conference Neutrons in Research and Industry; (1997) https://doi.org/10.1117/12.267878
Event: Fifth International Conference on Applications of Nuclear Techniques: Neutrons in Research and Industry, 1996, Crete, Greece
Abstract
The renewed interest in boron neutron capture therapy (BNCT) is driven mainly by the disappointing progress in the treatment of brain tumors by other modalities over the last decades. Even though molecular biology newer drugs and strategies may promise better results in the future, BNCT is an attractive approach. Brain tumors kill by local growth and not be metastases. Boron can be delivered to the tumor while normal brain is protected by the blood brain barrier, which can be disrupted to the degree desired. Tumor selectivity can be obtained not only by improved drug barrier, which can be disrupted to the degree desired. Tumor selectivity can be obtained not only by improved drug delivery but also by restricting the capture reaction to the region of interest by targeted radiation. Both boron drug and thermal neutrons alone are to some extent innocuous to tumor and normal tissues in this binary form of therapy. The pattern of treatment failure from uncontrolled primary tumor, the blood brain barrier protection of normal surrounding tissue and the limited range of epithermal neutrons explain why brain tumors are the main focus of BNCT research.
© (1997) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Reinhard Gahbauer, N. Gupta, T. Blue, J. Goodman, J. Grecula, A. H. Soloway, and A. Wambersie "BNCT: a promising area of research?", Proc. SPIE 2867, International Conference Neutrons in Research and Industry, (27 February 1997); https://doi.org/10.1117/12.267878
Lens.org Logo
CITATIONS
Cited by 2 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Tissues

Boron

Brain

Blood brain barrier

Clinical trials

Particles

RELATED CONTENT

Advances in antigenic vaccines for glioblastoma
Proceedings of SPIE (January 08 2024)
Boron neutron capture therapy: from physics to treatment
Proceedings of SPIE (February 27 1997)
Boron-neutron capture therapy
Proceedings of SPIE (March 03 1995)

Back to Top